Skip to content

Clinical trials

Myasthenia Gravis trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myasthenia Gravis Country / region: Belgium Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20152
20162
20171
20182
20194
20216
20221
20249
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting9
Active, not recruiting5
Enrolling by invitation1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx14
Alexion Pharmaceuticals, Inc.2
CuraVac2
Grifols Therapeutics LLC2
Momenta Pharmaceuticals, Inc.2
Centre Hospitalier Universitaire de Liege1
Janssen Research & Development, LLC1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1
NMD Pharma A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myasthenia Gravis31
Charcot-Marie-Tooth Disease1
Huntington Disease1
Lambert-Eaton Myasthenic Syndrome1
Multiple Sclerosis1
Muscular Dystrophy, Facioscapulohumeral1
Myotonic Dystrophy1
Neuromuscular Diseases1
Obesity1
Spastic Paraplegia, Hereditary1

Trials

Showing 51 to 31 of 31. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.